Meanwhile, they demonstrated the potential role of polymeric immunoglobulin receptor (PIGR), CRP, FRIL and fibrinogen as predictive biomarkers for CCA development in patients with PSC, before it is clinically evident. The gene discussed is PIGR; the disease is cholangiocarcinoma.